SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-12-208503
Filing Date
2012-05-03
Accepted
2012-05-03 16:14:19
Documents
4
Period of Report
2012-05-03
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d342554d8k.htm 8-K 12599
2 SHAREHOLDER LETTER d342554dex991.htm EX-99.1 22283
3 GRAPHIC g342554ex99_1pg004a.jpg GRAPHIC 3407
4 GRAPHIC g342554ex99_1pg004b.jpg GRAPHIC 6644
  Complete submission text file 0001193125-12-208503.txt   50235
Mailing Address 7 WELLS AVENUE STE 34 NEWTON MA 02459
Business Address 7 WELLS AVENUE STE 34 NEWTON MA 02459 617-559-0033
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31791 | Film No.: 12809869
SIC: 2834 Pharmaceutical Preparations